Please assess the completion status of the following clinical trial:

Trial Title: Extended Use of Polyethyleneglycol3350 Laxative in Constipated Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Male or female outpatients at least 18 years of age~* Constipated according to ROME I criteria~* On average, fewer than 3 satisfactory BMs per week during the observation period~* If female and of childbearing potential, patient must be surgically sterilized or using oral contraceptives, depot contraceptives, intrauterine device, or testifies that she is monogamous with a vasectomized partner, or practices abstinence and will continue to do so during the duration of study~* Are otherwise in good health, as judged by a physical examination~* In the investigator's judgment, patient is mentally competent to sign an instrument of informed consent~Exclusion Criteria:~* Patients with heme positive stool at screening. Patients with heme positive stool that can be attributed to hemorrhoids or anal fissures are eligible for inclusion.~* Patients with hypo- or hyperthyroidism as determined by history, or screening TSH results.~* Patients with known or suspected perforation or obstruction.~* History of gastric retention, inflammatory bowel disease, bowel resection, or colostomy.~* Patients with a known history of organic cause for their constipation.~* Patients meeting the ROME definition of Irritable Bowel Syndrome~* Patients currently taking any of the following medications that are known to effect bowel habits:~  * Antidiarrheals~ * Antacids containing magnesium or aluminum salts~ * Anticholinergics~ * Antispasmodic agents~ * Erythromycin and other macrolides~ * Octreotide~ * Lotronex, Zofran, or other 5-HT3 antagonists~ * Zelnorm, or other 5-HT4 agonists~ * Opiods/narcotic analgesics~ * Prokinetics~ * Serotonin re-uptake inhibitors or tricyclic antidepressants~ * Calcium antagonists~* Patients who are breastfeeding, pregnant, or intend to become pregnant during the study.~* Female patients of childbearing potential who refuse a pregnancy test.~* Patients with a known allergy to corn or polyethylene glycol.~* Patients who, in the opinion of the investigator, should not be included in the study for any reason, including inability to follow study procedures.~* Patients who, within the past 30 days have participated in an investigational clinical study~* Patients that have undergone a colonoscopy within 30 days of beginning the 14 day observation period.~* Patients that are currently taking, or have previously been treated with polyethyleneglycol3350

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: None

Based on this trial design, predict the completion outcome and termination type (if applicable).